Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Ultralente Insulin

Known as: Insulin ultralente, Insulin, Ultralente [Chemical/Ingredient], Insulin, Ultralente 
A long-acting form of crystalline insulin often used in combination with a short-acting insulin in the treatment of diabetes mellitus. Administered… Expand
National Institutes of Health

Related topics

Related topics

9 relations

Broader (2)

Hypoglycemic AgentsInsulin
In BloodInsulin ultralente:Mass:Pt:Dose:QnProcess of secretionaspects of radiation effects
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
Pharmacokinetic and glucodynamic variability: assessment of insulin glargine, NPH insulin and insulin ultralente in healthy volunteers using a euglycaemic clamp technique
Aims/hypothesisThis single-dose, double-blind, randomised, parallel-group study evaluated the reproducibility in systemic… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Highly Cited
2004
Highly Cited
2004
Strict insulin therapy normalises organ nitrogen contents and the capacity of urea nitrogen synthesis in experimental diabetes in rats
SummaryRats with experimental diabetes due to streptozotocin (75 mg/kg body weight) and free access to food were divided into two… Expand
  • table 1
  • table 2
  • table 3
Highly Cited
2002
Highly Cited
2002
Treatment satisfaction in type 2 diabetes: a comparison between an inhaled insulin regimen and a subcutaneous insulin regimen.
BACKGROUND In patients with type 2 diabetes, published data suggest that glycemic control can be achieved as effectively with an… Expand
Review
2002
Review
2002
Novel insulins: expanding options in diabetes management.
  • J. Gerich
  • The American journal of medicine
  • 2002
    • Corpus ID: 23694592
Management of type 1 and type 2 diabetes mellitus with intensive insulin therapy usually includes an intermediate- or long-acting… Expand
Highly Cited
2001
Highly Cited
2001
Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study
BACKGROUND Effective glycaemic control in type 1 diabetes mellitus usually requires two or more insulin injections daily. Inhaled… Expand
Highly Cited
1999
Highly Cited
1999
Effects of meal carbohydrate content on insulin requirements in type 1 diabetic patients treated intensively with the basal-bolus (ultralente-regular) insulin regimen.
OBJECTIVE In this study, we evaluated the effects of high-(55%) and low-(40%) carbohydrate diets on insulin requirements in nine… Expand
Highly Cited
1990
Highly Cited
1990
Quality of life in non-insulin-dependent diabetes and a comparison with insulin-dependent diabetes.
The reported effects of diabetes on quality of life have been assessed in two groups of attenders at out-patient clinics: 1. One… Expand
Highly Cited
1986
Highly Cited
1986
Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension.
Two groups of adult male Munich-Wistar rats and a third group of nondiabetic age-matched and weight-matched normal control rats… Expand
  • table I
  • figure 1
  • table II
  • figure 2
  • table III
Highly Cited
1985
Highly Cited
1985
Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy.
Six groups of Munich-Wistar rats underwent micropuncture study 2-10 weeks and morphologic studies 11-13 months after induction of… Expand
  • table 1
  • table 2
  • figure 1
  • figure 3
  • figure 2
Highly Cited
1985
Highly Cited
1985
Intranasal aerosolized insulin. Mixed-meal studies and long-term use in type I diabetes.
We assessed the efficacy of intranasal aerosolized insulin containing laureth-9 as a surfactant in patients with Type I diabetes… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE